Barbara Hickingbottom J.d., M.d.

Barbara Hickingbottom, J.D., M.D. is currently serving as the Chief Medical Officer at ASKGENE PHARMA, INC. since May 2022. Prior to this, they held various roles at Xencor, including Vice President Clinical Development from October 2019 to the present, and Senior Director, Clinical Development, Immuno-oncology from September 2016 to October 2019. Barbara also has experience as an Independent Consultant in Clinical Development and Medical Affairs since 2005. Earlier in their career, they worked as a Medical Director at Xoma from 2003 to 2004, and at Mannkind from 2001 to 2003.

Barbara Hickingbottom, J.D., M.D. attended Tufts University School of Medicine, where they obtained their M.D. degree. Barbara also attended Harvard Law School, where they earned their J.D. degree. Further details regarding the start and end years or field of study are unavailable.